Changes in platelet volume, morphology and RNA content in subjects treated with haemodialysis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 4, 2008, Pages 335-342

  Schoorl, M ^a   Bartels, P C M ^a  

^a Location Alkmaar   (Netherlands)

Author keywords

Haemodialysis; Immature platelet fraction; Mean platelet volume; Platelet; Platelet distribution width

Indexed keywords

RNA;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; MICROSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RNA ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE STRUCTURE; THROMBOCYTE VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CELL SHAPE; CELL SIZE; HUMANS; MIDDLE AGED; PLATELET COUNT; RENAL DIALYSIS; RNA;

EID: 46949101181     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510701744481     Document Type: Article

References (26)

1. De Sanctis LB, Stefoni S, Cianciolo G, Coli L, Buscaroli A, Feliciangeli G, et al. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation. Int J Artif Organs 1996;19:404-10.
2. Opatrny K Jr, Bouda M, Kohoutkova L, Sefrna F. A clinical study to assess the effect of heparin in dialyser rinsing solutions. Int J Artificial Organs 1997;20:112-18.
3. Sirolli V, Ballone E, Di Stante S, Amoros L, Bonomini M. Cell activation and cellular-cellular interactions during hemodialysis: Effect of dialyzer membrane. Int J Artif Organs 2002;25:529-37.
4. Sebekova K, Spustova V, Optatrny K Jr, Dzurik R. Serotonin and 5-hydroxyindole-acetic acid. Bratisl Lek Listy 2001;102:351-6.
5. Bartels PCM, Schoorl M, Schoorl M. Activatie van stolling tijdens hemodialyse is afhankelijk van de wijze van antistolling. Ned Tijdschr Klin Chem Labgeneesk 2005;30:282-4.
6. Schoorl M, Schoorl M, Bartels PCM. Platelet activation and serotonin release during treatment with haemodialysis. Ned Tijdschr Klin Chem Labgeneesk 2006;31:236-8.
7. Donati G, Ciancolo G, D'Addio F, Colì L, La Manna G, Feliciangeli G, et al. Platelet activation and PDGF-AB release during dialysis. Int J Artif Organs 2002;25:1128-36.
8. Ruf A, Patscheke H. Flowcytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and p-selectin expression. Semin Thromb Hemostasis 1995;21:146-51.
9. Kolde H-J. Primary haemostasis. In Haemostasis. Basel: Pentapharm; 2001. pp 12-19.
10. Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004;126:93-9.
11. Henning BF, Zidek W, Linder B, Tepel M. Mean platelet volume and coronary heart disease in hemodialysis patients. Kidney Blood Press Res 2002;25:103-8.
12. Ciancolo G, Stefoni S, Donati G, De Pascalis A, Iannelli S, Manna C, et al. Intra- and post-dialytic platelet activation and PDGF-AB release: Cellulose diacetate vs polysulfone membranes. Nephrol Dial Transplant 2001;16:1222-9.
13. Bain BJ. Blood sampling and film preparation/morphology. In Blood cells: A practical guide, 2nd edn. Blackwell Science, Oxford; 1995. pp 12 / pp 98-100.
14. Bartels PCM, Schoorl M, Schoorl M, Wiering JGA, Nubé MJ. Activation of coagulation during treatment with haemodialysis. Scand J Clin Lab Invest 2000;60:283-90.
15. Bartels PCM, Schoorl M, Schoorl M, Nubé MJ. Deviations in coagulation activation due to treatment with different haemodialysis membranes. Scand J Clin Lab Invest 2003;63:417-24.
16. Kuragano T, Kuno T, Takahashi Y, Yamamoto C, Nagura Y, et al. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation. Blood Purif 2003;21:176-82.
17. Chevallier M, Schoorl M, Schoorl M, van Tellingen A, Nubé MJ, Bartels PCM. Membrane dependent activation markers of platelets during treatment with haemodialysis. Ned Tijdschr Klin Chem 2001;26:100.
18. Gritters M, Borgdorff P, Grooteman MPC, Schoorl M, Schoorl M, Bartels PCM, et al. Reduction in platelet activation by citrate anticoagulation does not prevent intradialytic hemodynamic instability. Nephron Clin Pract 2007;106:c9-16.
19. Ando M, Iwamoto Y, Suda A, Tsuchiya K, Nihei H. New insights into the thrombopoietic status of patients on dialysis through evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood 2001;97:915-21.
20. Altun B, Arici M, Haznedaroglu IC, Usalan C, Erdem Y, Yasavul U, et al. Serum thrombopoietin levels in haemodialysis patients: Involvement of arteriovenous fistula. Nephrol Dial Transplant 1999;14:2173-7.
21. Abe Y, Wada H, Tomatsu H, Sakaguchi A, Nishioka J, Yabu Y, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 2006;118:463-9.
22. Briggs C, Hart D, Kunk S, Oguni S, Machin SJ. Immature platelet fraction measurement: A future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfusion Med 2006;16:101-9.
23. Rossi E, Casali B, Regolisti G, Davoli S, Perazzoli F, Negro A, et al. Increased plasma levels of platelet derived growth factor (PDGF BB+PDGF AB) in patients with never-treated mild essential hypertension. Am J Hypertens 1998;11:1239-43.
24. Tassies D, Reverter JC, Cases A, Escolar G, Villamor N, Lopez-Pedret J, et al. Reticulated platelets in uremic patients: Effect of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Hematol 1995;50:161-6.
25. Gresele P, Page C, Fuster V, Vermylen J. Aggregation. In Platelets in thrombotic and non-thrombotic disorders: Pathophysiology, pharmacology and therapeutics, 1st edn. Cambridge: Cambridge University Press; 2002. p 345.
26. Gritters M, Grooteman MPC, Schoorl M, Schoorl M, Bartels PCM, Scheffer PG, et al. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 2006;21:153-9.